FDA plans study into how patients and physicians make prescription decisions

The FDA’s Office of Prescription Drug Promotion (OPDP) wants to find out how patients and physicians weigh the tradeoffs between risks and benefits when starting a new prescription drug. What characteristics influence treatment choices and how do people reach the decision for one drug over another? The OPDP will be answering these questions through a new study.